PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 28, 2015

Primary Completion Date

June 11, 2016

Study Completion Date

May 27, 2017

Conditions

Respiratory Tract InfectionsUrinary Tract Infections in Children

Interventions

DRUG

Ceftriaxone Sodium and Sulbactam Sodium for Injection

daily dose was 75 mg/kg by weight, 1-2 times ivgtt per day, 4 to 14 days

All Listed Sponsors

lead

Xiangbei Welman Pharmaceutical Co., Ltd

INDUSTRY

NCT04066621 - PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT) | Biotech Hunter | Biotech Hunter